Streamline Health Solutions, Inc. (NASDAQ:STRM) Sees Significant Increase in Short Interest

Streamline Health Solutions, Inc. (NASDAQ:STRM) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 119,000 shares, an increase of 234.3% from the August 31st total of 35,600 shares. Based on an average trading volume of 183,800 shares, the days-to-cover ratio is currently 0.6 days.

Streamline Health Solutions Trading Up 6.2 %

NASDAQ STRM traded up $0.01 during trading on Wednesday, hitting $0.19. The company’s stock had a trading volume of 450,836 shares, compared to its average volume of 125,065. Streamline Health Solutions has a fifty-two week low of $0.14 and a fifty-two week high of $1.00. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. The business’s 50 day simple moving average is $0.44 and its 200-day simple moving average is $0.43.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.01). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

Institutional Investors Weigh In On Streamline Health Solutions

A hedge fund recently bought a new stake in Streamline Health Solutions stock. Mesirow Financial Investment Management Inc. purchased a new position in shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 123,900 shares of the company’s stock, valued at approximately $59,000. Mesirow Financial Investment Management Inc. owned 0.21% of Streamline Health Solutions as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 31.74% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th. StockNews.com began coverage on Streamline Health Solutions in a report on Monday. They set a “sell” rating for the company.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.